Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Rivanna Medical, Inc. · Predicate Candidate Screening

5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

119 daysmedian FDA review time
291 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K261014Accuro® 3S Needle Guide KitRivanna Medical, Inc.2026-07-241190
K253452Accuro 3SRivanna Medical, Inc.2026-07-242910
K254021Accuro XVRivanna Medical, Inc.2026-04-091140
K250469Accuro® 3S Needle Guide KitRivanna Medical, Inc.2025-06-131150
K243937Accuro 3SRivanna Medical, Inc.2025-05-231540

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda